• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    ACG Launches ACG Laboratories

    Glatt and Aprecia Enter 3D-Printing Collaboration

    Catalent Acquires Delphi Genetics

    Almac Group Completes $7M R&D Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing

    PwC Joins Medicines Manufacturing Innovation Centre

    AARDEX Group Partners with Pill Connect

    Phillips-Medsize and Subcuject Collaborate
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement

    Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions

    Pfizer Selects Seven Bridges to Support RNA Sequencing Data

    ACG Launches ACG Laboratories

    Catalent Acquires Delphi Genetics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    test company saurabh

    Almac Group

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Reed-Lane

    Aphena Pharma Solutions

    Alcami

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    WHO Lauds India’s Vaccine Safety

    The World Health Organization endorses India’s regulation of vaccines even as desi players try their hands in more advanced v

    Related CONTENT
    • MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
    • Intravacc Unveils New Pilot Vaccine Production Facility
    • Pfizer, BioNTech To Supply 200M More Vax Doses to EU
    • Novavax, SK Bioscience Expand Vax Pact
    • FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site
    S. Harachand, Contributing Editor04.03.17
    The World Health Organization (WHO) has rated India as one of the most stringent regulators of vaccines in the world. In the latest grading, WHOs team of experts assessed India’s National Regulatory Authority (NRA) across nine different functionalities, which include quality of the regulatory system, marketing authorization, regulatory inspection, clinical trial oversight and licensing premises.

    NRA for vaccines, as defined by WHO, in India is a multi-level system comprising the Pharmacovigilance Programme of India (PvPI) and the Adverse Events Following Immunization (AEFI)—the country’s drug safety watchdogs—as well as the central and state regulators responsible for approvals and licensing of vaccines and clinical trials.
    Following an audit in February, the UN agency found India’s NRA ‘functional’ with a maturity level rating of 4 for five functions, and a maturity level of 3 for the rest. Four is the highest maturity level under WHO’s Global Benchmarking Tool for measuring the maturity of a country’s regulatory systems.

    The maturity level 4 indicates good results and sustained improvement trends, whereas maturity level 3 reflects systematic process-based approach, early stage of systematic improvements, data availability regarding conformance to objectives, and existence of improvement trends, according to WHO’s official release.

    Meeting the standards of the WHO-published NRA indicators is critical for those countries that manufacture and export vaccines. It is also an essential criterion for obtaining and maintaining WHO prequalification status. Manufacturers can seek pre-qualification only if the respective NRA fulfills the norms set by the WHO Global Benchmarking Tool. Since India is a major supplier of vaccines to UNICEF, the endorsement is expected to give more impetus to the local vaccine manufacturers.

    The new WHO rating, which is higher than the one the global agency performed last time in 2012, will also help India to position itself in the league of regulators noted for their tougher standards on the quality and safety of vaccines such as in the U.S., Japan and EU countries. 

    Indian firms supply as much as 60% of vaccines for the Global Alliance for Vaccines and Immunization (GAVI). The non-profit organization, in turn, makes it available to 73 low and middle-income nations across the world.

    Many firsts?
    Largely known for low-cost, basic vaccines, manufacturers from India are rapidly getting into more complex, technologically advanced vaccines business. Recent launches and the active research pipelines of some leading Indian vaccine makers indicate this trend.

    Serum Institute of India (SII), which commercialized an intra-nasal version of H1N1 influenza vaccine, is currently working with international agencies including WHO, PATH, NIH,CBER/FDA to develop vaccines against diseases like meningococcal A, flu and rotavirus infection. The privately owned SII is presently the world’s largest vaccine maker by the number of doses produced, according to the company website.

    Bharat Bio, which claims to be the first to seek a global patent for a Zika vaccine candidate, is having a pipeline of chikungunya, MSRA, HPV vaccines at early stages of development.

    Panacea Biotec announced a long-term supply agreement with UNICEF for its pentavalent (DTwP+Hep B+Hib) vaccine early this year. Panacea’s fully liquid vaccine requires no reconstitution and therefore is easier to administer. Panacea Biotec has also introduced inactivated polio vaccine in association with the Institute for Translational Vaccinology, the Netherlands.

    Meanwhile, a few others are pursuing direct collaborations with global leaders in the vaccine field for securing technologies they are lacking.

    Cadila Pharma of Ahmedabad, Gujarat is a case in point. The company started a joint venture CPL Biologicals Pvt. Ltd. with Novavax Inc., way back in 2009 for exploring the latter’s virus like particle (VLP) technology for producing vaccines.

    According to Cadila, utilization of the VLP know-how considerably speeds up the overall production process. The technology cuts short the development time for the new strain-specific vaccine by more than half, compared to the conventional vaccines development methods. In November last year, CPL Bio launched VLP-based seasonal influenza vaccine Cadiflu S in India.

    Cadiflu S is the world’s first VLP vaccine against seasonal flu, claimed CPL. The company has the capacity to produce up to 25 million doses of the vaccine every year. Working on a robust pipeline of vaccine candidates against pancreatic cancer, human papilloma virus, varicella zoster virus, hepatitis E, CPL is now planning to build another factory near Ahmedabad for vaccines.

    Biological E joined hands with GSK and Novartis for developing combo vaccines and typhoid vaccines. This privately-held vaccine firm is setting up an additional vaccine facility as part of its $150 million investment plan at Genome Valley near Hyderabad. Production of vaccines in the new plant is expected to start by December 2019. 


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Related Searches
    • capacity
    • events
    • cancer
    • pipeline
    Suggested For You
    MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
    Intravacc Unveils New Pilot Vaccine Production Facility Intravacc Unveils New Pilot Vaccine Production Facility
    Pfizer, BioNTech To Supply 200M More Vax Doses to EU Pfizer, BioNTech To Supply 200M More Vax Doses to EU
    Novavax, SK Bioscience Expand Vax Pact Novavax, SK Bioscience Expand Vax Pact
    FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site
    Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine
    RotaChrom Technologies Partners with Cyclolab RotaChrom Technologies Partners with Cyclolab
    Masy BioServices Expands Green Initiative Masy BioServices Expands Green Initiative
    Inside a Vaccine Trial Inside a Vaccine Trial
    CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants
    J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate
    The Future of Vaccines and Biologics The Future of Vaccines and Biologics
    Vaxart Oral COVID-19 Vax Tablet Shows Promise Vaxart Oral COVID-19 Vax Tablet Shows Promise
    UK Secures 40M Doses of Valneva COVID-19 Vax UK Secures 40M Doses of Valneva COVID-19 Vax
    Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine

    Related Back Page

    • Aseptic Processing | Facilities | Fill/Finish | Parenterals
      The Future of Pharmaceutical Manufacturing

      The Future of Pharmaceutical Manufacturing

      Innovative multi-product facility and equipment design.
      Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21

    • Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Cell & Gene Therapy Supply Chain: Early Preparation is Key

      Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
      Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | R&D
      The Global Biotech Boom

      The Global Biotech Boom

      How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.
      Davide Garrisi, PPD Biotech 09.09.20


    • Speeding Vaccine Development with Advanced Analytics

      Speeding Vaccine Development with Advanced Analytics

      Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development process
      Dr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20

    • APIs
      SOPs to Spur Growth in API Manufacturing

      SOPs to Spur Growth in API Manufacturing

      CMOs see outsourcing prospects improve
      S. Harachand, Contributing Editor 04.01.20

    • Trends Affecting the Generic Drugs Sector in 2020

      Trends Affecting the Generic Drugs Sector in 2020

      Supply chain issues, the need for additional talent chemists, lower drug prices, growth of development in the U.S. will be key factors.
      Ed Price, President, Seqens NA 03.04.20


    • QA/QC
      Quality Management: Preserving and Perpetuating Your Record

      Quality Management: Preserving and Perpetuating Your Record

      CDMOs must ensure that their top priority be delivering the highest quality products.
      Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20

    • Injectables
      Pitfalls to Avoid When Packaging Injectable Drug Products

      Pitfalls to Avoid When Packaging Injectable Drug Products

      Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.
      Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19


    • Clinical Trials | Information Technology
      Virtual Trials: Are they living up to their hype?

      Virtual Trials: Are they living up to their hype?

      This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain
      Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA 09.16.19

    • Avoiding Death by Spreadsheet

      Avoiding Death by Spreadsheet

      Cloud ERP systems are ushering in a new era of supply chain management
      Michael Kolias, QAD 06.13.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biotech Booms in the Yangtze River Valley

      Biotech Booms in the Yangtze River Valley

      A look at forces shaping the course of biotech growth in China
      Daniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19


    • India Eases Price Control  On Novel Drugs

      India Eases Price Control On Novel Drugs

      No price cap for innovator products for 5 years
      S. Harachand, Contributing Editor 03.06.19

    • Logistics | Supply Chain
      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      Pharma Distribution: Powering the Supply Chain Today & Shaping What’s Next

      The role of pharmaceutical distributors in the increasingly complex supply chain
      Akin Odutola, AmerisourceBergen 01.25.19

    • Injectables | Parenterals
      Injectables Go Deeper

      Injectables Go Deeper

      Generic majors set sights on complex sterile injectables
      S. Harachand, Contributing Editor 11.14.18

    Trending
    • Century Therapeutics Significantly Expands Capabilities
    • Catalent Acquires Delphi Genetics
    • Sanofi And Translate Bio Expand Vaccine Collaboration
    • RotaChrom Technologies Partners With Cyclolab
    • Wavelength Pharmaceuticals Acquires Majority Stake In Vanamali Organics
    Breaking News
    • Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    • Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    • ACG Launches ACG Laboratories
    • Glatt and Aprecia Enter 3D-Printing Collaboration
    • Catalent Acquires Delphi Genetics
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test
    NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    ACG Launches ACG Laboratories
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Afro Sheen Launches New Brand Initiatives
    Neopac Introduces Lightweight Plastic Tube
    Estée Lauder Companies Increases Investment in Deciem Beauty Group Inc.
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Ontex Reports Lower Revenues
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoGrid Releases New Hip Replacement Software
    Nexus Spine Announces Availability of Spine Surgery Implants
    FDA OKs Brainlab's Loop-X Mobile Imaging Robot, Cirq Robotic Alignment Module
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login